一种用于原发性硬化性胆管炎无移植生存的新型预后模型
研究基于荷兰692例和英国264例原发性硬化性胆管炎(PSC)患者,回顾性收集临床和生化变量,采用多变量Cox回归和LASSO方法构建并外部验证预测PSC相关死亡和肝移植的预后模型。最终模型纳入PSC亚型、诊断年龄、白蛋白、血小板、天冬氨酸氨基转移酶、碱性磷酸酶和胆红素,C统计量为0.68(95%CI 0.51至0.85),校准良好。
要点
- Amsterdam-Oxford模型纳入PSC亚型、诊断年龄、白蛋白、血小板、AST、ALP和胆红素。
- 模型预测PSC相关死亡和/或肝移植的C统计量为0.68(95%CI 0.51至0.85),校准良好。
- 更新生化指标后可重新计算无移植生存概率。
核心结论
- Amsterdam-Oxford模型在主要以人群为基础的环境中,对估计PSC相关死亡和/或肝移植表现出足够性能。
研究设计与样本
- 推导队列为荷兰692例PSC患者,验证队列为英国264例PSC患者,回顾性收集临床和生化变量。
- 采用多变量Cox回归模型,通过LASSO选择预测变量并估计参数,构建预后指数。
- 复合终点为PSC相关死亡和肝移植。
主要发现
- 最终模型包含变量:PSC亚型、PSC诊断时年龄、白蛋白、血小板、天冬氨酸氨基转移酶、碱性磷酸酶和胆红素。
- C统计量为0.68(95%CI 0.51至0.85),校准满意。
- 基于随访时收集的生化变量进行预测时,C统计量不变,模型稳健。
关键数值与推荐
- C统计量0.68(95%CI 0.51至0.85)用于量化模型预测价值。
临床怎么用
- 更新生化值可用时,可重新计算无移植生存概率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Most prognostic models for primary sclerosing cholangitis (PSC) are based on patients referred to tertiary care and may not be applicable for the majority of patients with PSC. The aim of this study was to construct and externally validate a novel, broadly applicable prognostic model for transplant-free survival in PSC, based on a large, predominantly population-based cohort using readily available variables. DESIGN: The derivation cohort consisted of 692 patients with PSC from the Netherlands, the validation cohort of 264 patients with PSC from the UK. Retrospectively, clinical and biochemical variables were collected. We derived the prognostic index from a multivariable Cox regression model in which predictors were selected and parameters were estimated using the least absolute shrinkage and selection operator. The composite end point of PSC-related death and liver transplantation was used. To quantify the models' predictive value, we calculated the C-statistic as discrimination index and established its calibration accuracy by comparing predicted curves with Kaplan-Meier estimates. RESULTS: The final model included the variables: PSC subtype, age at PSC diagnosis, albumin, platelets, aspartate aminotransferase, alkaline phosphatase and bilirubin. The C-statistic was 0.68 (95% CI 0.51 to 0.85). Calibration was satisfactory. The model was robust in the sense that the C-statistic did not change when prediction was based on biochemical variables collected at follow-up. CONCLUSION: The Amsterdam-Oxford model for PSC showed adequate performance in estimating PSC-related death and/or liver transplant in a predominantly population-based setting. The transplant-free survival probability can be recalculated when updated biochemical values are available.
引用
- de Vries EM, Wang J, Williamson KD, et al. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut. 2017. PMID: 28739581. doi:10.1136/gutjnl-2016-313681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。